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Background: Early aggressive therapy can reduce the mortality associated with severe sepsis but this relies on
prompt recognition, which is hindered by variation among published severity criteria. Our aim was to test the
performance of different severity scores in predicting mortality among a cohort of hospital inpatients with sepsis.
Methods: We anonymously linked routine outcome data to a cohort of prospectively identified adult hospital
inpatients with sepsis, and used logistic regression to identify associations between mortality and demographic
variables, clinical factors including blood culture results, and six sets of severity criteria. We calculated performance
characteristics, including area under receiver operating characteristic curves (AUROC), of each set of severity criteria
in predicting mortality.
Results: Overall mortality was 19.4% (124/640) at 30 days after sepsis onset. In adjusted analysis, older age (odds
ratio 5.79 (95% CI 2.87-11.70) for ≥80y versus <60y), having been admitted as an emergency (OR 3.91 (1.31-11.70)
versus electively), and longer inpatient stay prior to sepsis onset (OR 2.90 (1.41-5.94) for >21d versus <4d), were
associated with increased 30 day mortality. Being in a surgical or orthopaedic, versus medical, ward was associated
with lower mortality (OR 0.47 (0.27-0.81) and 0.26 (0.11-0.63), respectively). Blood culture results (positive vs.
negative) were not significantly association with mortality. All severity scores predicted mortality but performance
varied. The CURB65 community-acquired pneumonia severity score had the best performance characteristics
(sensitivity 81%, specificity 52%, positive predictive value 29%, negative predictive value 92%, for 30 day mortality),
including having the largest AUROC curve (0.72, 95% CI 0.67-0.77).
Conclusions: The CURB65 pneumonia severity score outperformed five other severity scores in predicting risk of
death among a cohort of hospital inpatients with sepsis. The utility of the CURB65 score for risk-stratifying patients
with sepsis in clinical practice will depend on replicating these findings in a validation cohort including patients
with sepsis on admission to hospital.
Keywords: Sepsis, Severity, Risk scores, Outcomes, Mortality, CURB, CURB65, Systemic inflammatory response
syndrome, SIRSBackground
Sepsis carries a high risk of death, with estimated mortality
rates for severe sepsis of up to 50% [1,2]. There is a sub-
stantial body of evidence that early initiation of aggressive
therapy can reduce mortality [3,4], but this requires prompt
recognition. Sepsis has been defined as the systemic inflam-
matory response syndrome (SIRS, Table 1) due to infection
[5], with severe sepsis defined as sepsis with resulting organ
hypoperfusion or dysfunction. Inconsistency exists across* Correspondence: c.z.marwick@dundee.ac.uk
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reproduction in any medium, provided the ortrials and guidelines as to the level of dysfunction, and of
which organs, required to qualify as having severe sepsis
[3,6-11]. This makes generalising research findings and de-
veloping local evidence-based clinical guidelines and proto-
cols difficult. A simple and standardised way of identifying
high risk sepsis patients is required to aid timely thera-
peutic decision-making.
Severity criteria designed to identify high risk patients are
available, but it is unclear which criteria perform best in
identifying people who have the highest mortality risk
among those with sepsis. Potentially useful severity assess-
ment tools for sepsis include generic tools such as thel Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Tested severity criteria with the scoring system or severe sepsis definition from each
Severity criteria Scoring system/severe sepsis definition
Systemic inflammatory response
syndrome (SIRS) [5]
Two or more of (means SIRS): heart rate ≥90 beats/minute, respiratory rate ≥20 breaths/minute,
temperature <36 or ≥38°C, white blood cell count <4 or ≥12 cells/mm3
Standardised early warning system
(SEWS) score [12]
Sum of scores allocated for each clinical observation:* respiratory rate, oxygen saturation, temperature,
SBP, heart rate, stimulus required to invoke a response
CURB65 pneumonia severity score [16] One point for each of: new confusion, urea >7 mmol/l, respiratory rate ≥30 breaths/min, SBP <90 mmHg
or DBP ≤60 mmHg, age ≥65 years
Institute for Healthcare Improvement
website [8]
One or more of (means severe sepsis): SBP <90 mmHg or decreased by >40 mmHg, MAP <70 mmHg,
lactate >2 mmol/l, SpO2 ≤90%, urine output <30 ml/hr, creatinine >177 mmol/l, INR >1.5, APTT >60secs,
platelets <100/mm3, bilirubin >35 mmol/l
Surviving Sepsis Campaign guidelines
2008 [7]
One or more of (means severe sepsis): SBP <90 mmHg or decreased by >40 mmHg, MAP <70 mmHg,
lactate >4 mmol/l, oliguria, altered mental status
Survive Sepsis™ website [13] One or more of (means severe sepsis): SBP <90 mmHg, MAP <65 mmHg, lactate >2 mmol/l, SpO2 ≤90%,
urine output <30 ml/hr, creatinine >177 mmol/l, INR >1.5, APTT >60secs, platelets <100/mm3,
bilirubin >34 mmol/l
SBP = systolic blood pressure, DBP = diastolic blood pressure, MAP =mean arterial blood pressure, INR = international normalised ratio, APTT = activated partial
thromboplastin time.
*Graded scores of 0–3 allocated for each observation, detailed in Additional file 1: Table S1.
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and sepsis-related criteria such as the number of SIRS cri-
teria met [5] or the criteria for severe sepsis from the Insti-
tute for Healthcare Improvement (IHI) [8], the Surviving
Sepsis Campaign (SSC) 2008 guidelines [7], or Survive Sep-
sis UK [13] (Table 1). A patient’s SEWS score (Table 1 and
Additional file 1: Table S1) on admission to hospital corre-
lated with in-hospital mortality and length of stay in a pro-
spective audit [12], and meeting higher numbers of SIRS
criteria has been associated with worse outcome in patients
with bacteraemia [14] and with pneumonia [15]. The
CURB65 severity score, which predicts mortality among pa-
tients with community-acquired pneumonia [16], may also
apply to patients with sepsis. Despite being developed and
validated in a different patient group, the criterion that
make up the CURB65 score (Table 1) are each, with the ex-
ception of age, indicators of organ dysfunction, which in
the context of sepsis means severe sepsis. The CURB65
score has been reported to correlate with mortality in emer-
gency department patients with any infection [17], and we
propose the score may also apply to hospital inpatients.
In this study, we evaluated the extent to which the
above six sets of severity criteria and other clinical and
demographic variables, were associated with 30 and
90 day mortality among a cohort of hospitalised patients
who developed sepsis. We then compared the perform-
ance characteristics of each set of severity criteria in pre-
dicting mortality, and tested the potential to improve
performance further by adding clinical variables to the
best performing set of severity criteria.
Methods
Setting and data description
Ninewells Hospital is an 860-bedded, tertiary, teaching hos-
pital serving the Scottish region of Tayside, which has apopulation of approximately 400,000. In this cohort study
we retrospectively analysed data that had been collected
prospectively. We identified patients who developed sepsis
while inpatients in Ninewells Hospital in two cohorts, from
September 2008 to February 2009 and October 2009 to
March 2010, as part of a larger quality improvement project
[18]. The study case definition was: an adult (≥18 years old)
patient with sepsis occurring ≥24 h after admission to hos-
pital, either as a first episode of sepsis or following a period
of ≥24 h without meeting SIRS criteria. Patients with im-
mune compromise due to chemotherapy or organ trans-
plant were excluded. For the first cohort we screened
patients who had blood cultures taken while in any hospital
ward except paediatrics, obstetrics, haematology, oncology,
acute admissions units, and the accident and emergency
department, to identify patients meeting the study case def-
inition. In pilot work, we demonstrated that screening pa-
tients who had blood cultures taken (regardless of whether
positive or negative) had good performance characteristics
for identifying patients with sepsis [18]. For the second co-
hort we restricted screening to general medical, general sur-
gical, and orthopaedic wards (due to the design of the
improvement project), which included 22 of the 30 wards
screened for the first cohort.
The prospectively collected clinical data, which included
the patient’s clinical measurements at sepsis onset, comor-
bidity, and demographics, were anonymised in a study
database, with a Charlson Index of comorbidity [19] calcu-
lated for each patient. We linked these to routine data via
the Health Informatics Centre (HIC), University of Dun-
dee, using patients’ unique community health index (CHI)
numbers. The Scottish Morbidity Record (SMR) databases
accessed for this study were: SMR01 general acute in-
patient and day case discharges, General Register Office
for Scotland (GRO) death registrations, and the NHS
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ture results and a Scottish Index of Multiple Deprivation
(SIMD) quintile [20] for all patients and dates of all deaths
up to 90 days after the end of data collection. Because the
cohort included mainly older adults, we defined the age
groups as <60 yrs, 60-69 yrs, 70-79 yrs and ≥80 yrs for
analysis. We categorised blood culture results, from seven
days before to seven days after sepsis onset, as positive,
probable contaminant, or negative. The categorisation of
isolated organisms was done by two Infectious Diseases
physicians (CM and PD, authors) and a consultant micro-
biologist (GP, acknowledgements) (see Additional file 2:
Table S2 for how we classified the isolated organisms). Pa-
tients were grouped according to their “most positive”
blood culture result, so a patient with a positive culture
and a probable contaminant was grouped as positive, and
a patient with a probable contaminant and a negative cul-
ture was grouped as probable contaminant. In classifying
sepsis severity, when the data item required for a severity
criterion was not available we classified the patient as not
meeting that criterion. This risked underestimating sever-
ity but reflected real-life performance of the criteria. For
all definitions of severe sepsis, organ dysfunction must be
new and distant from the site of infection, so we took
comorbidity, previous blood results, and the site of in-
fection into account when classifying severity criteria.
Data analysis
We calculated 30 and 90 day mortality and used binary
logistic regression to examine associations with age, gen-
der, SIMD quintile [20], Charlson Index of comorbidity
[19], admission type, ward type at sepsis onset, length of
inpatient stay prior to sepsis onset, blood culture result,
and by sepsis severity according to each set of criteria,
with results reported as odds ratios (OR) with 95% con-
fidence intervals (CI). We then used multivariate regres-
sion to adjust for variables associated with mortality in
univariate analysis (p < 0.10). Each set of severity criteria
was analysed in a separate multivariate model due to
overlaps in criteria.
We assessed the performance of each set of severity
criteria for predicting death in two ways. Firstly, we cal-
culated the sensitivity, specificity, positive predictive
value (PPV), and negative predictive value (NPV) for
each set, expressed as percentages. For the severity
scores that are not binary, we tested different cut-off
values for classification as severe versus not severe and
selected the best performing cut-off. Secondly, we pro-
duced receiver operator characteristics (ROC) curves for
each set of criteria and calculated the area under the
ROC curves (AUROC) with 95% CIs. The null hypoth-
esis for ROC curve interpretation is that the AUROC =
0.5. An AUROC closer to 1.0 indicates better perform-
ance. Finally, we created novel severity criteria by addingclinical variables associated with mortality to high per-
forming existing criteria, and calculated the AUC.
For all data management and analysis we used Microsoft
Access 2007 and SPSS Statistics 17.0.
Ethics and approvals
The study was approved by the Tayside Medical Re-
search Ethics Committee A, who deemed that informed
consent was not required as data were observational, ex-
tracted from routine care records, and anonymised for
analysis. The Caldicott Guardian for inpatients gave per-
mission to access the data.
Results
Mortality summary
There were 339 eligible patients in the first cohort and
302 in the second cohort. The two cohorts were the
same in terms of age, gender, Charlson Index of comor-
bidity, and SIRS criteria (Chi-squared tests p > 0.2 for
each comparison) so they were combined. Outcome data
were missing for one patient, leaving 640 patients for
analysis. Death within 30 days of sepsis onset occurred
in 124/640 (19.4%, 95% CI 16.3-22.4%) patients. A fur-
ther 56 patients died between 31 and 90 days, meaning
90 day mortality was 28.1% (180/640, 95% CI 24.6-
31.6%). Mean survival among those who died within
90 days was 24.0 days (95% CI 20.8-27.2), and median
survival 16.5 days (interquartile range (IQR) 7.0-36.0).
Distribution of the cohort by demographic and clinical
characteristics and six sets of severity criteria, along with
the mortality in each variable category, are given in
Table 2. The minimum number of SIRS criteria was two
because of the sepsis case definition. Of note, in 24%
(150/633) of cases blood cultures were positive, in 66%
(418) they were negative and in the remaining 10% (65)
a probable contaminant organism was isolated (Table 2
and Additional file 2: Table S2).
Logistic regression
In univariate logistic regression analysis, increasing age
and comorbidity were associated with increased mortal-
ity. Having been admitted as an emergency, longer stays
in hospital prior to sepsis onset, and being in a medical
ward, were also each associated with increased mortality,
but blood culture results had little association. Higher
scores against all six sets of severity criteria were associ-
ated with increased mortality, but the SEWS score was
least, and CURB65 most, discriminant (Table 2).
Gender and SIMD were excluded from multivariate
analysis due to lack of association in univariate analysis.
Other variables were included in the adjusted models for
the severity criteria, except age was excluded from the
CURB65 model because age forms part of the score.
Older age remained associated with increased mortality
Table 2 Cohort distribution of mortality by demographic and clinical variables and by severity criteria
Variable Category N in
category+
30 day
mortality
OR (95% CI) for death
within 30 days
90 day
mortality
OR (95% CI) for death
within 90 days
Age group <60 yrs 171 8% 1.00 13% 1.00
60–69 yrs 127 9% 1.06 (0.47–2.43) 10% 0.73 (0.36–1.51)
70–79 yrs 174 20% 2.82 (1.46–5.47)** 31% 2.90 (1.68–4.99)**
≥80 yrs 168 38% 6.90 (3.68–12.95)** 53% 7.43 (4.35–12.66)**
Gender Male 351 18% 1.00 27% 1.00
Female 289 21% 1.22 (0.83–1.81) 30% 1.16 (0.82–1.64)
SIMD quintile 1 Deprived 130 19% 1.00 26% 1.00
2 107 21% 1.09 (0.57–2.06) 30% 1.21 (0.68–2.13)
3 115 24% 1.35 (0.74–2.49) 36% 1.56 (0.91–2.70)
4 161 18% 0.92 (0.51–1.67) 28% 1.10 (0.65–1.84)
5 Affluent 111 18% 0.92 (0.48–1.77) 24% 0.91 (0.51–1.63)
Charlson index 0 133 12% 1.00 16% 1.00
1 170 15% 1.33 (0.68–2.60) 24% 1.71 (0.95–3.06)
2 137 22% 2.03 (1.05–3.93)* 32% 2.50 (1.39–4.49)**
≥3 200 26% 2.57 (1.40–4.73)** 37% 3.13 (1.81–5.42)**
Admission type Elective 129 3% 1.00 5% 1.00
Emergency 511 23% 9.59 (3.47–26.50)** 34% 10.59 (4.57–24.51)**
Ward type Medicine 281 30% 1.00 40% 1.00
Surgery 244 11% 0.28 (0.17–0.45)** 16% 0.30 (0.20–0.45)**
Orthopaedics 68 10% 0.27 (0.12–0.61)** 21% 0.39 (0.21–0.74)**
Other 47 15% 0.41 (0.18–0.95)* 29% 0.64 (0.33–1.25)
Length of stay prior to sepsis onset 1–3 days 187 11% 1.00 17% 1.00
4–7 days 139 18% 1.83 (0.97–3.45) 27% 1.83 (1.07–3.13)*
8–21 days 213 23% 2.50 (1.42–4.38)** 33% 2.52 (1.56–4.06)**
>21 days 101 29% 3.53 (1.88–6.63)** 40% 3.44 (1.98–5.98)**
Blood culture result Negative 418 18% 1.00 26% 1.00
Contaminant 65 22% 1.22 (0.64–2.31) 32% 1.39 (0.79–2.44)
Positive 150 21% 1.20 (0.76–1.91) 34% 1.50 (1.00–2.24)*
SIRS criteria 2 227 13% 1.00 22% 1.00
3 279 19% 1.60 (0.98–2.62) 29% 1.51 (1.01–2.27)*
4 132 31% 3.08 (1.80–5.26)* 36% 2.08 (1.29–3.34)**
SEWS score 0–1 95 15% 1.00 26% 1.00
2–3 242 15% 1.01 (0.52–1.97) 19% 0.66 (0.38–1.15)
4–5 182 21% 1.53 (0.78–2.99) 35% 1.48 (0.86–2.57)
≥6 121 30% 2.45 (1.23–4.88)** 38% 1.72 (0.96–3.09)
CURB65 score 0 112 3% 1.00 6% 1.00
1 179 11% 4.57 (1.33–15.76)* 17% 3.14 (1.33–7.41)**
2 190 23% 10.95 (3.31–36.19)** 34% 7.80 (3.43–17.74)**
≥3 159 36% 20.30 (6.17–66.87)** 48% 14.09 (6.17–32.17)**
IHI criteria Not severe 431 14% 1.00 23% 1.00
Severe 207 29% 2.49 (1.66–3.72)** 39% 2.11 (1.48–3.02)**
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Table 2 Cohort distribution of mortality by demographic and clinical variables and by severity criteria (Continued)
SSC criteria Not severe 468 14% 1.00 22% 1.00
Severe 172 34% 3.24 (2.15–4.88)** 45% 2.87 (1.98–4.17)**
Survive Sepsis criteria Not severe 450 15% 1.00 23% 1.00
Severe 188 30% 2.53 (1.69–3.80)** 39% 2.13 (1.48–3.07)**
+Total N = 640 except for SIMD (N = 624) blood culture results (N = 633).
*p ≤ 0.05, **p < 0.01.
Odds ratios (OR) with 95% confidence intervals (CI) for likelihood of death associated with each variable category from univariate logistic regression are given.
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tween comorbidity and death were much weaker, and
only significant for 90 day mortality with Charlson
Index ≥3 in some models (OR 1.73-2.13, p 0.03-0.09,
across all models). Having been admitted as an emer-
gency remained associated with increased 30 day mor-
tality (OR 3.82-4.35, p ≤ 0.02 in all models). Being in a
surgical, or orthopaedic, ward at sepsis onset was asso-
ciated with lower adjusted 30 day mortality compared
to being in a medical ward (OR 0.44-0.49, and 0.17-
0.26, respectively across all models, p < 0.01 in all in-
stances). Having an inpatient stay of >21 days before
sepsis onset was also still associated with increased
30 day mortality (OR 2.81-3.10, p < 0.01 in all models)
(data not shown). Blood culture results had no associ-
ation with mortality in the adjusted models.
All sets of severity criteria were significantly associated
with mortality in adjusted models (Table 3). For SIRS
criteria and SEWS scores, associations with mortality
were only significant in the highest category, and only atTable 3 Adjusted likelihood of death associated with severity
Severity criteria Category 30 day mortality OR (95%
SIRS criteria 2 1.00
3 1.44 (0.83–2.49)
4 2.36 (1.29-4.33)
SEWS score 0–1 1.00
2–3 1.06 (0.50–2.24)
4–5 1.36 (0.65–2.87)
≥6 2.20 (1.02–4.75)
CURB65 score 0 1.00
1 3.90 (1.10–13.81)
2 8.93 (2.60–30.67)
≥3 16.97 (4.92–58.55)
IHI criteria Not severe 1.00
Severe 2.64 (1.66–4.21)
SSC criteria Not severe 1.00
Severe 3.16 (1.98–5.05)
Survive Sepsis criteria Not severe 1.00
Severe 2.66 (1.65–4.27)
Odds ratios from multivariate logistic regression models. All models were adjusted
length of hospital stay prior to sepsis onset and blood culture result, and all model30 days. Each increase in CURB65 score had a stepwise
increase in the adjusted odds of death, with scores of
three or more having 12 times increased risk of death
compared to a score of zero (Table 3). The other three
sets of severity criteria all had significant associations
with mortality (Table 3), with similar odds ratios to
those in the univariate models (Table 2).
Performance characteristics of severity criteria
The performance characteristics for predicting 30 day
mortality for each set of severity criteria are given in
Table 4, including the mortality among those below the
best cut-off value for each. SIRS criteria (cut-off of ≥3)
had reasonable sensitivity, but had the lowest specificity
of all criteria (Table 4). The SEWS score (cut-off ≥4) was
more specific but at the expense of sensitivity. The
CURB65 score (cut-off ≥2) performed best, with PPV al-
most as good as any other set of criteria and much
stronger other performance characteristics (Table 4).
CURB65 had the lowest mortality among patients belowcriteria category
CI) P value 90 day mortality OR (95% CI) P value
- 1.00 -
0.197 1.26 (0.78–2.03) 0.350
0.005 1.39 (0.80–2.42) 0.242
- 1.00 -
0.874 0.61 (0.32–1.17) 0.137
0.413 1.36 (0.72–2.60) 0.346
0.045 1.32 (0.66–2.63) 0.430
- 1.00 -
0.035 2.48 (1.02–6.04) 0.046
0.001 5.81 (2.45–13.75) <0.001
<0.001 10.39 (4.33–24.93) <0.001
- 1.00 -
<0.001 2.20 (1.42–3.40) <0.001
- 1.00 -
<0.001 2.68 (1.73–4.15) <0.001
- 1.00 -
<0.001 2.12 (1.36–3.30) 0.001
for Charlson Index of comorbidity, admission type, ward type at sepsis onset,
s except CURB65 were adjusted for age.
Table 4 Performance characteristics of each severity criteria
Severity criteria Performance characteristics for 30 day mortality AUROC (95% CI)
Mortality below cut-off value Sensitivity Specificity PPV NPV 30 day mortality 90 day mortality
SIRS criteria 13% 76% 38% 23% 87% 0.61 0.57
(29/227) (94/123) (198/515) (94/411) (198/227) (0.55–0.67) (0.52–0.62)b
SEWS score 15% 60% 56% 24% 85% 0.60 0.59
(50/337) (74/124) (287/516) (74/303) (287/337) (0.54–0.66) (0.54–0.65)
CURB65 score 8% 81% 52% 29% 92% 0.72 0.72
(23/291) (101/124) (268/516) (101/349) (268/291) (0.67–0.77) (0.67–0.76)
IHI criteria 14% 50% 72% 29% 86% 0.61 0.59
(62/431) (61/123) (369/515) (61/207) (369/431) (0.55–0.66) (0.54–0.64)
SSC criteria 14% 48% 78% 34% 86% 0.63 0.61
(65/468) (59/124) (403/516) (59/172) (403/468) (0.57–0.69) (0.56–0.66)
Survive Sepsis criteria 15% 46% 75% 30% 85% 0.61 0.58
(66/450) (57/123) (384/515) (77/188) (384/450) (0.55–0.66) (0.53–0.63)
aPositive predictive value equals the mortality rate above the cut-off value for each set of criteria.
bp = 0.004, (p ≤ 0.001 for all other AUROC).
Area under receiver operating characteristics curves AUROC = (with 95% CI) for the ability of each set of severity criteria to predict 30 and 90 day mortality.
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above and below it (29% versus 8%). The other three sets
of criteria had very similar performance characteristics,
due to similar inclusion criteria (Table 4).
The AUROC with 95% CIs for each set of severity cri-
teria, for 30 and 90 day mortality, are given in Table 4. The
ROC curves for 30 day mortality are given in Figure 1 and
Figure 2. CURB65 had the largest AUROC at 0.72 for both
30 and 90 day mortality. The other severity criteria had
AUROC between 0.60 and 0.63 at 30 days, and 0.57 and
0.61 at 90 days (Table 4). Of the existing criteria, theFigure 1 Area under receiver operating characteristics curves
(AUROC) for 30 day mortality by SIRS criteria, SEWS score and
CURRB65 score.CURB65 score performed best so we used it to test whether
performance improved further with the addition of clinical
variables that were significantly associated with mortality in
the adjusted regression analysis. Thus, we allocated a point
for each of: emergency admission; admitted ≥21 days prior
to sepsis onset, and; medical ward at sepsis onset. Adding
each of these points to the CURB65 score in different com-
binations resulted in small increases in AUROC (detailed in
Additional file 3: Table S3). The addition of all three re-
sulted in an AUC of 0.77 for both 30 and 90 day mortality
(see Additional file 3: Table S3).Figure 2 Area under receiver operating characteristics curves
(AUROC) for 30 day mortality by IHI, SSC and Survive Sepsis
severity criteria.
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Among a large cohort of prospectively identified hospital
inpatients who developed sepsis during their admission, we
found high mortality rates that were highest among older
patients, emergency admissions, patients in medical wards
at sepsis onset, patients with longer inpatient stays prior to
sepsis onset, and those who scored highly on any of the
severity criteria tested. The CURB65 severity score for
community-acquired pneumonia performed best at pre-
dicting mortality.
The 30 day mortality rate in this cohort was similar to
that previously reported for septic patient populations
[1,2,6,14]. Evidence is accumulating that the effect of sepsis
on mortality extends beyond 30 days [21,22], and extending
follow up to 90 days in our study detected 50% more deaths
than at 30 days. Associations between mortality and ward
type, and whether the admission was emergency or elective,
suggest that these variables indicate comorbidity and/or
frailty in addition to that detected by the Charlson Index.
The Scottish standardised mortality ratio [23], used for na-
tional recording and reporting, accounts for these factors,
indicating that such associations are established. The lack
of associations between Charlson comorbidity and mor-
tality in adjusted analysis may be partly because the
Index was developed and validated for predicting mor-
tality at one year among general inpatient populations
[19], rather than at shorter timeframes among septic
inpatients. The Charlson Index was developed in the
1980′s so is outdated, with excessive weighting for a
diagnosis of “AIDS”, but it is still the most extensively
validated comorbidity measure available. The study
cohort only included one HIV positive patient so this
limitation of Charlson will not have impacted signifi-
cantly on the study results.
We found that blood culture results were not associated
with mortality, consistent with others’ findings [14,24,25].
Obtaining positive blood cultures depends on many vari-
ables including the pathogen, host, site of infection, prior
antibiotics, and sampling [26], so blood culture positivity is
an inconsistent feature in sepsis of any severity. Sepsis stud-
ies only recruiting patients with positive blood cultures will
miss many cases.
The SIRS criteria were designed to indicate the presence
of the systemic inflammatory response syndrome, and not
to predict outcome or for use as a graded severity scale.
However, associations between the number of SIRS criteria
and mortality in unselected blood culture patients [14] and
patients with community-acquired pneumonia [15] have
been observed. The SEWS score was designed to identify
patients at risk of deterioration and cardiac arrest to aid pri-
oritisation and organisation of urgent medical care, rather
than to predict outcome. In a prospective audit of 435 pa-
tients, SEWS scores on admission correlated with in-
hospital mortality (p < 0.001) and length of stay (p < 0.001),unadjusted for other variables [12]. SIRS and SEWS scores
at sepsis onset did not perform as well in our adjusted
analysis.
The CURB65 score was designed to risk-stratify patients
with community-acquired pneumonia (CAP) on admis-
sion to hospital according to risk of death. It has been vali-
dated in large international cohorts in that context [16]
but it has not been validated for use during the hospital
admission [27]. The components of the CURB65 score
(Table 1) are measures of organ dysfunction which in the
context of sepsis indicate severe sepsis. This may explain
why it performed well at predicting mortality in this
cohort. A large prospective study of emergency depart-
ment patients with any suspected infection reported
that CURB65 scores correlated with in-hospital 28-day
mortality, with increased odds of death of 2.4 (95% CI
2.0-3.0) with each score increase [17]. A cohort study
comparing the performance characteristics of SIRS cri-
teria, SEWS scores, and CURB65 scores in predicting
mortality after CAP found CURB65 performed best
[15]. The authors therefore argued against suggestions
that generic sepsis severity scores could be applied to
CAP patients [15,27]. Our findings indicate that the
converse may be true, that severity scores developed
for CAP can be applied to patients with sepsis from
any source, at least those with onset in hospital.
The other three sets of published sepsis severity cri-
teria come from clinical guidelines to aid the identifica-
tion of patients with severe sepsis that may benefit from
more aggressive therapy. The criteria and the number of
patients identified as severe varied slightly but the per-
formance characteristics were similar for all three, and
were outperformed by CURB65 scores.
Two additional sets of criteria for risk stratification to
predict mortality among blood culture patients [28], and
deterioration among patients with early sepsis [29] have
been proposed. Both are cumbersome, requiring mul-
tiple data items from a variety of sources and stratifica-
tion into four levels of risk, and at least one has not
been tested at individual patient level at the bedside
[30]. The clinical application of severity tools has been
described as dependent on three factors: 1) the accurate
prediction of the outcome of interest; 2) the ability to
classify patients into clinically useful groups (e.g. by level
of risk); 3) simplicity [27,31]. The CURB65 score con-
forms to these factors, it is already in routine clinical use
for CAP, four of the five required criteria are assessable
clinically and the fifth (blood urea) a simple laboratory
test available even in low technology settings. The addition
of further clinical variables to the CURB65 score in our
study led to only very small improvements in performance,
the benefit of which would be outweighed by the added
complexity and the potential difficulty in rapidly determin-
ing the additional variables. Biomarkers have been
Marwick et al. BMC Anesthesiology 2014, 14:1 Page 8 of 9
http://www.biomedcentral.com/1471-2253/14/1increasingly proposed as useful tools in identifying patients
with infection and guiding therapy. However, biomarkers
such as procalcitonin are not yet widely available and are
expensive, and the added value of using procalcitonin
across inpatient populations has not yet been demon-
strated. One study found that a commonly measured and
widely available inflammatory protein, C-reactive protein
(CRP), improved the CURB65 AUROC for 30 day mortal-
ity among CAP patients [32], but this requires validation in
further studies [27].
A major strength of this study was the combination of
prospectively collected detailed clinical data with rou-
tinely collated data from population databases. There
were very few missing data items, we used validated
measures of comorbidity and deprivation, and we were
able to follow patients up after hospital discharge. One
limitation of applying severe sepsis criteria to this cohort
was that blood lactate level in particular was not avail-
able for all patients. Another limitation in testing sever-
ity criteria, common to all such studies, is that the
analysis is based on a one-off set of clinical recordings
rather serial sets of recordings. In a prospective study
of patients admitted with skin and soft tissue infec-
tions, we found that the worst set of recordings in
the initial 24 hours was more predictive of illness se-
verity and outcome than the first set [33], although
prompt treatment relies on decision-making on the
data available at onset.Conclusions
Severe sepsis, as identified by any severity criteria, has sig-
nificant associated mortality. It is necessary to promptly
identify high risk patients to aid therapeutic decision mak-
ing, and guide prognosis. In selecting severity criteria
there will always be a trade-off between high sensitivity
(with the risk of over-treating some patients) and high
positive predictive value (with the risk of missing some
patients). We should also emphasise that any severity
scoring system should be used along with, and not in
place of, clinical judgement in therapeutic decision mak-
ing. In our large cohort of septic hospital inpatients, the
CURB65 score outperformed other measures of illness se-
verity in predicting mortality, showing promise for such
use in clinical practice. Testing in a validation cohort of
septic patients, including those on admission to hospital,
would help clarify its applicability.Additional files
Additional file 1: Table S1. SEWS score detail.pdf contains a table
entitled “Standardised early warning system (SEWS) scores allocated for
each clinical observation” giving additional information on this scoring
system with the relevant reference from the literature.Additional file 2: Table S2. Classification of blood culture isolates.pdf
contains a table entitled “Classification of all organisms isolated from
blood cultures in study patients” in which isolated organisms are
classified into whether they are likely pathogens or contaminants.
Additional file 3: Table S3. AUROC curves with extra variables.pdf
contains a table entitled “AUROC curves for severity criteria created by
adding further clinical variables to the CURB65 score” demonstrating
changes made to the area under receiver operating characteristics curves
made by adding clinical variables to the CURB65 score for community
acquired pneumonia.
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